Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation - A White Paper

Pancreas

Volumn 44, Issue 5, 2015, Pages 686-692

  Kenner, Barbara J ^a   Chari, Suresh T ^b   Cleeter, Deborah F ^c   Go, Vay Liang W ^d  

^a Kenner Family Research Fund   (United States)

^b MAYO CLINIC   (United States)

^c Sawgrass Leadership Institute   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarker; early detection; imaging; pancreatic cancer; screening; sporadic

Indexed keywords

CLINICAL PRACTICE; COMMERCIAL PHENOMENA; CONFERENCE PAPER; EARLY DIAGNOSIS; GOVERNMENT; HUMAN; IMAGING; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; RESEARCH PRIORITY; SCIENTIST; STANDARD; BIOPSY; CARCINOMA, PANCREATIC DUCTAL; COOPERATION; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; GENETICS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MASS COMMUNICATION; MEDICAL RESEARCH; METABOLISM; MOLECULAR DIAGNOSIS; MORTALITY; ORGANIZATION AND MANAGEMENT; PANCREATIC NEOPLASMS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS;

TUMOR MARKER;

BIOMARKERS, TUMOR; BIOMEDICAL RESEARCH; BIOPSY; CARCINOMA, PANCREATIC DUCTAL; COOPERATIVE BEHAVIOR; DIAGNOSTIC IMAGING; DIFFUSION OF INNOVATION; EARLY DETECTION OF CANCER; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MOLECULAR DIAGNOSTIC TECHNIQUES; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84932632413     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000369     Document Type: Conference Paper

References (30)

1. Trends in SEER incidence and U.S. mortality using the Joinpoint Regression Program, 1975-2011 with up to five Joinpoints, 1992-2011 with up to three Joinpoints, both sexes by race/ethnicity. Available at: http://seer.cancer.gov/csr/1975-2011/results-merged/sect-22-pancreas.pdf#search=pancreatic. Accessed April 1, 2015.
2. National Cancer Institute: Surveillance, Epidemiology, and End Results Program (SEER): turning cancer data into discovery. Available at: http://seer.cancer.gov/faststats/. Accessed April 1, 2015.
3. Fortner JG, Klimstra DS, Senie RT, et al. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg. 1996;223:147-153.
4. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913-2921.
5. Chari ST, Kelly K, Hollingsworth MA, et al. Early detection of sporadic pancreatic cancer: summative review. Pancreas. 2015;44:693-712.
6. Hruban RH, Canto MI, Goggins M, et al. Update on familial pancreatic cancer. Adv Surg. 2010;44:293-311.
7. Kern S, Hruban R, Hollingsworth MA, et al. Awhite paper: the product of a pancreas cancer think tank. Cancer Res. 2001;61:4923-4932.
8. Chari ST, Leibson CL, Rabe KG, et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005;129:504-511.
9. Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170:403-413.
10. Eshleman JR, Norris AL, Sadakari Y, et al. KRAS and Guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol. 2015;13:963-969.e4.
11. Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142: 796-804; quiz e714-e795.
12. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287-1297.
13. Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol. 2013;11:1313-1318.
14. Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012;142:248-256; quiz e225-e246.
15. Zhang L, Farrell JJ, Zhou H, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138:949-957; e941-e947.
16. Sugimoto M, Wong DT, Hirayama A, et al. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6:78-95.
17. Yan W, Apweiler R, Balgley BM, et al. Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl. 2009;3:116-134.
18. Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15:5473-5477.
19. Hu Z, Zimmermann BG, Zhou H, et al. Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem. 2008;54:824-832.
20. Denny P, Hagen FK, Hardt M, et al. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res. 2008;7:1994-2006.
21. Carrara S, Cangi MG, Arcidiacono PG, et al. Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies. Am J Gastroenterol. 2011;106:1359-1363.
22. Pedersen JW, Blixt O, Bennett EP, et al. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. Int J Cancer. 2011;128:1860-1871.
23. Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell. 2012;148:349-361.
24. Rhim AD, Thege FI, Santana SM, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 2014;146:647-651.
25. Seufferlein T, Bachet JB, Van Cutsem E, et al. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(suppl 7):vii33-vii40.
26. Dewitt J, Devereaux BM, Lehman GA, et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4:717-725; quiz 664.
27. Hocke M, Ignee A, Dietrich CF. Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis. Endoscopy. 2011;43:163-165.
28. Dietrich CF, Wehrmann T, Hoffmann C, et al. Detection of the adrenal glands by endoscopic or transabdominal ultrasound. Endoscopy. 1997;29:859-864.
29. Saftoiu A, Vilman P. Endoscopic ultrasound elastography - a new imaging technique for the visualization of tissue elasticity distribution. J Gastrointestin Liver Dis. 2006;15:161-165.
30. Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284-294.